[go: up one dir, main page]

DE60221541D1 - Ernährungszusammensetzungen zur kontrolle des blutzuckerspiegels - Google Patents

Ernährungszusammensetzungen zur kontrolle des blutzuckerspiegels

Info

Publication number
DE60221541D1
DE60221541D1 DE60221541T DE60221541T DE60221541D1 DE 60221541 D1 DE60221541 D1 DE 60221541D1 DE 60221541 T DE60221541 T DE 60221541T DE 60221541 T DE60221541 T DE 60221541T DE 60221541 D1 DE60221541 D1 DE 60221541D1
Authority
DE
Germany
Prior art keywords
blood sugar
lipid
carbohydrate
diet
controlling
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60221541T
Other languages
English (en)
Other versions
DE60221541T2 (de
Inventor
Kenji Mizumoto
Hajime Sasaki
Hisae Kume
M Yamaguchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meiji Dairies Corp
Original Assignee
Meiji Dairies Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27347461&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60221541(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Meiji Dairies Corp filed Critical Meiji Dairies Corp
Publication of DE60221541D1 publication Critical patent/DE60221541D1/de
Application granted granted Critical
Publication of DE60221541T2 publication Critical patent/DE60221541T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/30—Artificial sweetening agents
    • A23L27/33—Artificial sweetening agents containing sugars or derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/328—Foods, ingredients or supplements having a functional effect on health having effect on glycaemic control and diabetes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/332—Promoters of weight control and weight loss

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Emergency Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Pediatric Medicine (AREA)
  • Virology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60221541T 2001-09-07 2002-09-06 Ernährungszusammensetzung zur kontrolle des blutzuckerspiegels Expired - Lifetime DE60221541T2 (de)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
JP2001272463 2001-09-07
JP2001272463 2001-09-07
JP2002073141 2002-03-15
JP2002073141 2002-03-15
JP2002160602 2002-05-31
JP2002160602 2002-05-31
PCT/JP2002/009092 WO2003022288A1 (en) 2001-09-07 2002-09-06 Nutritional compositions for controlling blood glucose level

Publications (2)

Publication Number Publication Date
DE60221541D1 true DE60221541D1 (de) 2007-09-13
DE60221541T2 DE60221541T2 (de) 2007-11-22

Family

ID=27347461

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60221541T Expired - Lifetime DE60221541T2 (de) 2001-09-07 2002-09-06 Ernährungszusammensetzung zur kontrolle des blutzuckerspiegels

Country Status (17)

Country Link
US (2) US7641924B2 (de)
EP (1) EP1424074B1 (de)
JP (1) JP3545760B2 (de)
KR (1) KR100926944B1 (de)
CN (3) CN101897947A (de)
AT (1) ATE368467T1 (de)
AU (1) AU2002330496B2 (de)
BR (1) BR0212369A (de)
CA (1) CA2458325C (de)
DE (1) DE60221541T2 (de)
DK (1) DK1424074T3 (de)
ES (1) ES2289142T3 (de)
HK (1) HK1247107A1 (de)
MY (1) MY135783A (de)
NZ (1) NZ531255A (de)
TW (2) TWI332399B (de)
WO (1) WO2003022288A1 (de)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1482920B2 (de) * 2002-02-12 2011-07-20 Hunza di Pistolesi Elvira & C. S.a.S. Zusammensetzungen enthaltend n-acyl-phosphatidyl-ethanolamin und/oder mischungen von n-acyl-ethanolaminen mit phosphatidinsäuren oder lysophosphatidinsäuren
SE526943C2 (sv) * 2002-08-26 2005-11-22 Indevex Ab Födoämneskompositionsprodukt
CN100448374C (zh) * 2002-11-18 2009-01-07 三井制糖株式会社 血糖值上升抑制剂、体脂肪蓄积抑制剂以及食用材料
JP4048166B2 (ja) * 2002-11-18 2008-02-13 三井製糖株式会社 血糖値上昇抑制剤及び体脂肪蓄積抑制剤並びに食用材料
JP4851902B2 (ja) * 2002-11-18 2012-01-11 三井製糖株式会社 体脂肪蓄積抑制剤
TWI317636B (en) * 2002-11-22 2009-12-01 Meiji Dairies Corp Nutritional compositions for liver disease patients or for patients underhigh levels of invasive stress
KR20050115927A (ko) * 2003-03-24 2005-12-08 세레스타 홀딩 비.브이. 지속적인 탄수화물 에너지 방출 및 감소된글리코스/인슐린 감응 및 삼투압유지를 위한 이소말툴로즈및 트레할로즈를 함유하는 식료품
DE10324548A1 (de) * 2003-05-28 2004-12-16 Nutrinova Nutrition Specialties & Food Ingredients Gmbh Diätisches Lebensmittel bei einer gewichtskontrollierenden bzw. gewichtsreduzierenden Ernährung
US20100222259A1 (en) * 2004-07-09 2010-09-02 Hidekazu Arai Compositions for enhancing the production of PPAR and/or PPAR-associated factors
US8231925B2 (en) 2004-08-20 2012-07-31 Cargill, Incorporated Ingredient systems comprising trehalose, food products containing trehalose, and methods of making same
JP2008510469A (ja) 2004-08-20 2008-04-10 カーギル インコーポレイテッド トレハロースを含む成分系、トレハロースを含む食品、およびこれらを作製する方法
CN101242748A (zh) * 2004-11-26 2008-08-13 荷兰纽迪希亚公司 含有蛋白酶抑制剂的婴儿营养品
JP4893907B2 (ja) * 2005-03-11 2012-03-07 公立大学法人島根県立大学 １型糖尿病用献立判定装置および１型糖尿病用献立判定プログラム
US8283327B2 (en) * 2005-03-19 2012-10-09 Kneller Bruce W Palatinose for enhancing dietary supplement and pharmaceutical delivery
JP5000874B2 (ja) * 2005-03-29 2012-08-15 三井製糖株式会社 スクラーゼ活性又はグルコアミラーゼ活性を阻害する剤
WO2006108008A2 (en) * 2005-04-06 2006-10-12 Novartis Ag A method and composition for nutritionally improving glucose control and insulin action
RU2385647C2 (ru) * 2005-08-26 2010-04-10 Нестек С.А. Питание для пациентов, страдающих ожирением
US20070166354A1 (en) 2005-10-26 2007-07-19 Bridget Barrett-Reis Method of reducing the risk of retinopathy of prematurity in preterm infants
JPWO2007060947A1 (ja) * 2005-11-22 2009-05-07 サンスター株式会社 健康食用組成物並びにそれを用いた健康食及び健康食セット
EP2363028A1 (de) * 2006-03-23 2011-09-07 Nestec S.A. Hochkalorischer Nahrungsmittelzusatz
KR20090003282A (ko) * 2006-03-31 2009-01-09 메이지 데어리즈 코포레이션 항지방축적용 조성물
NZ601174A (en) * 2006-04-07 2013-10-25 Megmilk Snow Brand Co Ltd Fat accumulation inhibitor
DE102006017611A1 (de) * 2006-04-12 2007-10-25 Südzucker AG Mannheim/Ochsenfurt Kohlenhyrathaltige Sportgetränke
EP1880612A1 (de) * 2006-07-17 2008-01-23 Corman S.A. Milchbestandteil enthaltend Polarlipide und deren Verwendung
PL1886585T3 (pl) * 2006-07-24 2009-04-30 Unilever Nv Ulepszony napój
WO2008046865A2 (en) * 2006-10-19 2008-04-24 Nestec S.A. Long-term feed - elderly
JP4814774B2 (ja) * 2006-12-06 2011-11-16 花王株式会社 肥満調節剤の評価方法
JP5208428B2 (ja) * 2007-01-30 2013-06-12 雪印メグミルク株式会社 美肌剤
WO2008093848A1 (ja) * 2007-02-02 2008-08-07 Sunstar Inc. ホスファチジルコリンを含有する炎症マーカー低減組成物
DE102007009029A1 (de) * 2007-02-23 2008-09-04 Südzucker AG Mannheim/Ochsenfurt Niedrig-glykämische Mischungen
FR2918543A1 (fr) * 2007-07-09 2009-01-16 Routinsa Sa Compositions alimentaires enrichies en acides insatures a base de graines d'oleagineux.
RU2471371C2 (ru) * 2007-12-05 2013-01-10 Н.В. Нютрисиа Обогащенная белком жидкая энтеральная питательная композиция на основе мицеллярного казеина
DE102008007072A1 (de) 2008-01-31 2009-08-13 Südzucker Aktiengesellschaft Mannheim/Ochsenfurt Verfahren zur Herstellung fermentierbarer Getränke
JPWO2009096579A1 (ja) * 2008-02-01 2011-05-26 味の素株式会社 高血糖抑制用栄養組成物
EP2100604B1 (de) 2008-03-10 2012-07-04 Nestec S.A. Dicarboxylsäuren von mittlerer Kettenlänge und ihre Derivate und Stoffwechselstörungen
CA2676518A1 (en) * 2008-08-29 2010-02-28 Kraft Foods Global Brands Llc Whey protein pre-load
US20100267658A1 (en) 2009-04-15 2010-10-21 Sudzucker Aktiengesellschaft Mannheim/Ochsenfurt Trehalulose-containing composition, its preparation and use
WO2011112074A1 (en) * 2010-03-11 2011-09-15 N.V. Nutricia Novel glucose tolerance test and composition for use
EP2584921B1 (de) * 2010-06-28 2015-05-27 Nestec S.A. Sondenernährungspackungen und verfahren zu ihrer verwendung
JP2012116795A (ja) * 2010-12-01 2012-06-21 Nisshin Oillio Group Ltd インスリン分泌促進剤
WO2012073965A1 (ja) * 2010-12-01 2012-06-07 日清オイリオグループ株式会社 インスリン分泌促進剤
WO2012074375A1 (en) * 2010-12-01 2012-06-07 N.V. Nutricia Prevention or treatment of overweight and obesity in type 2 diabetic patients
JP5905246B2 (ja) * 2010-12-16 2016-04-20 日清オイリオグループ株式会社 インスリン分泌促進剤
JP5718293B2 (ja) 2011-09-15 2015-05-13 花王株式会社 Ｇｉｐ上昇抑制剤
US9897565B1 (en) 2012-09-11 2018-02-20 Aseko, Inc. System and method for optimizing insulin dosages for diabetic subjects
US9171343B1 (en) 2012-09-11 2015-10-27 Aseko, Inc. Means and method for improved glycemic control for diabetic patients
CA2889348A1 (en) * 2012-10-25 2014-05-01 Run Them Sweet, LLC Methods and systems to estimate nutritional needs of human and other patients and to support such nutritional needs
USD743972S1 (en) * 2013-02-22 2015-11-24 Samsung Electronics Co., Ltd. Graphic user interface for a display screen or a portion thereof
USD742390S1 (en) * 2013-02-22 2015-11-03 Samsung Electronics Co., Ltd. Graphic user interface for a display screen or a portion thereof
DE102013011977A1 (de) 2013-07-18 2015-01-22 Südzucker Aktiengesellschaft Mannheim/Ochsenfurt Optimiertes Verfahren zur Herstellung einer Isomaltulose-haltigen Zusammensetzung
US9486580B2 (en) 2014-01-31 2016-11-08 Aseko, Inc. Insulin management
US9898585B2 (en) 2014-01-31 2018-02-20 Aseko, Inc. Method and system for insulin management
EP3050023B1 (de) 2014-10-27 2021-08-25 Aseko, Inc. Subkutane ambulante verwaltung
US11081226B2 (en) 2014-10-27 2021-08-03 Aseko, Inc. Method and controller for administering recommended insulin dosages to a patient
US9467745B1 (en) 2015-04-06 2016-10-11 Domo, Inc. Viewer traffic visualization platform
USD779524S1 (en) * 2015-04-06 2017-02-21 Domo, Inc. Display screen or portion thereof with a graphical user interface for analytics
USD780213S1 (en) 2015-04-06 2017-02-28 Domo, Inc. Display screen or portion thereof with an animated graphical user interface
USD778933S1 (en) 2015-04-06 2017-02-14 Domo, Inc. Display screen or portion thereof with a graphical user interface
USD836655S1 (en) 2015-04-06 2018-12-25 Domo, Inc Display screen or portion thereof with a graphical user interface
WO2016205701A1 (en) 2015-06-19 2016-12-22 University Of Southern California Enteral fast access tract platform system
WO2016205754A1 (en) 2015-06-19 2016-12-22 University Of Southern California Compositions and methods for modified nutrient delivery
USD769908S1 (en) * 2015-08-07 2016-10-25 Domo, Inc. Display screen or portion thereof with a graphical user interface for analytics
JP6858751B2 (ja) 2015-08-20 2021-04-14 アセコー インコーポレイテッド 糖尿病管理療法アドバイザ
CN105532869A (zh) * 2015-12-08 2016-05-04 石家庄君乐宝乳业有限公司 持续提供能量的无蔗糖风味发酵乳及其制备方法
US11388922B2 (en) * 2016-04-11 2022-07-19 Societe Des Produits Nestle S.A. Infant nutrition delivering metabolic benefits
CN105995980B (zh) * 2016-05-20 2019-04-05 武汉天天好生物制品有限公司 一种具有体重管理作用的组合物及其制备方法
EP3534884A1 (de) * 2016-11-04 2019-09-11 Immd SP. Zo.o Intelligente abgabe von aufgenommenen und absorbierten molekülen
WO2018225055A1 (en) * 2017-06-09 2018-12-13 A1C Foods Ltd. Satiating edible compositions having low glycemic index value, and methods of producing and consuming same
CN111227254A (zh) * 2020-02-27 2020-06-05 赫斯提亚健康科技(无锡)有限公司 一种用于辅助降血糖的碳水化合物组合
CN116473125A (zh) * 2022-01-17 2023-07-25 内蒙古伊利实业集团股份有限公司 一种缓释碳水组合物以及应用
CN117678742A (zh) * 2023-12-29 2024-03-12 舟山麦琳生物工程有限公司 营养制剂及其应用
CN118452453A (zh) * 2024-05-29 2024-08-09 华中农业大学 一种用于糖尿病预防和前驱糖尿病干预的饮食配方及应用

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5215834A (en) 1975-07-12 1977-02-05 Ajinomoto Kk Method of producing food composition
JPS63112963A (ja) 1986-10-30 1988-05-18 Mitsui Seito Kk 特殊飲食物
US5116819A (en) * 1989-05-05 1992-05-26 Clintec Nutrition Co. Enteral diet for patients with pulmonary disease
US5198250A (en) * 1990-07-16 1993-03-30 Lipotech Partners Limited Partnership Food and pharmaceutical compositions containing short chain monounsaturated fatty acids and methods of using
US5104676A (en) * 1991-06-27 1992-04-14 Abbott Laboratories Weight control product
US5256640A (en) * 1991-09-30 1993-10-26 Sandoz Ltd. Gallstone mitigation by nutrient stimulated gallbladder contraction
US5260336A (en) * 1992-04-30 1993-11-09 New England Deaconess Hospital Corporation Monounsaturated fat as dietary supplement to minimize the effects of catabolic illness
US5470839A (en) 1993-04-22 1995-11-28 Clintec Nutrition Company Enteral diet and method for providing nutrition to a diabetic
NZ260933A (en) 1993-07-16 1996-07-26 Hercules Inc Cation-complexed polysaccharides; use in foods and pharmaceuticals
US5714472A (en) * 1993-12-23 1998-02-03 Nestec Ltd. Enternal formulation designed for optimized nutrient absorption and wound healing
US5605893A (en) * 1994-03-15 1997-02-25 Children's Hospital Of Los Angeles Method of using a therapeutic food composition to diminish blood sugar fluctuations in diabetic patients
US5843921A (en) * 1994-03-15 1998-12-01 Childrens Hospital Of Los Angeles Therapeutic food composition and method to diminish blood sugar fluctuations
DE19528461A1 (de) * 1995-08-03 1997-02-06 Braun Melsungen Ag Präparat zur Ernährung
MY115050A (en) 1995-10-16 2003-03-31 Mead Johnson Nutrition Co Diabetic nutritional product having controlled absorption of carbohydrate
DE69731016T2 (de) * 1996-03-04 2005-10-06 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Herstellung einer Trehalulose enthaltende Polysaccharidzusammensetzung.
BR9708656A (pt) * 1996-04-12 2000-01-04 Beth Israel Hospital Barra suplementar para diabéticos
SE517520C2 (sv) * 1997-06-19 2002-06-11 Haldex Brake Prod Ab Anordning för lufttorkning försedd med omkopplingsventil i luftledning mellan luftkompressor och lufttorkare
EP1310173B2 (de) 1997-06-23 2014-12-31 Société des Produits Nestlé S.A. Zusammensetzung zur Ernährung von Diabetikern
JP3855486B2 (ja) * 1997-10-17 2006-12-13 味の素株式会社 キシリトールの製造法
JP3302346B2 (ja) 1999-10-08 2002-07-15 株式会社ファンケル 食品組成物
JP3195594B2 (ja) 1999-11-02 2001-08-06 明治乳業株式会社 乳由来のリン脂質を配合した食品組成物。
WO2001033976A1 (en) * 1999-11-08 2001-05-17 Childrens Hospital Los Angeles Research Institute Methods for regulating blood glucose and appetite suppression in type 2 diabetics
US6207638B1 (en) * 2000-02-23 2001-03-27 Pacifichealth Laboratories, Inc. Nutritional intervention composition for enhancing and extending satiety
US6248375B1 (en) * 2000-03-14 2001-06-19 Abbott Laboratories Diabetic nutritionals and method of using
PL203804B1 (pl) * 2000-06-27 2009-11-30 Hoffmann La Roche Sposób wytwarzania kompozycji farmaceutycznej w postaci spoistej, płytkowej, piankowej, gąbczastej lub ciastowatej struktury i kompozycja farmaceutyczna otrzymana tym sposobem
EP1309250A2 (de) 2000-08-08 2003-05-14 Advanced Functional Foods International, Inc. Nahrungsergänzungsmittel zur regulierung des menschlichen körpergewichts

Also Published As

Publication number Publication date
AU2002330496B2 (en) 2007-08-09
EP1424074B1 (de) 2007-08-01
KR100926944B1 (ko) 2009-11-17
DK1424074T3 (da) 2007-10-01
US20050002988A1 (en) 2005-01-06
CN1553805A (zh) 2004-12-08
ATE368467T1 (de) 2007-08-15
CA2458325C (en) 2011-08-02
TWI332399B (en) 2010-11-01
WO2003022288A1 (en) 2003-03-20
KR20040044455A (ko) 2004-05-28
TW201036618A (en) 2010-10-16
TWI359021B (en) 2012-03-01
EP1424074A4 (de) 2004-11-17
CA2458325A1 (en) 2003-03-20
US7815947B2 (en) 2010-10-19
US7641924B2 (en) 2010-01-05
CN107875118A (zh) 2018-04-06
US20090143277A1 (en) 2009-06-04
DE60221541T2 (de) 2007-11-22
JPWO2003022288A1 (ja) 2004-12-24
MY135783A (en) 2008-06-30
ES2289142T3 (es) 2008-02-01
CN101897947A (zh) 2010-12-01
BR0212369A (pt) 2004-08-17
NZ531255A (en) 2005-08-26
JP3545760B2 (ja) 2004-07-21
HK1247107A1 (zh) 2018-09-21
EP1424074A1 (de) 2004-06-02

Similar Documents

Publication Publication Date Title
DE60221541D1 (de) Ernährungszusammensetzungen zur kontrolle des blutzuckerspiegels
IT1291113B1 (it) Composizione nutritiva terapeutica per soggetti affetti da diabete mellito
CA2325379A1 (en) Composition for improving glucose and insulin metabolism in companion animals
DE69632745D1 (de) Zusatznahrung für kindpatienten
WO2001052667A3 (en) Pet food composition for treating helicobacter species in pets
ATE508648T1 (de) Kalorien- und faserstoffreiche flüssige nahrungszusammensetzung für die darmgesundheit älterer patienten
ATE534398T1 (de) Munddesinfektionsmittel und nahrungsmittelzusatz mit diesem desinfektionsmittel
Huang et al. Analysis of cariogenic potential of alternative milk beverages by in vitro Streptococcus mutans biofilm model and ex vivo caries model
ATE334688T1 (de) Zusammensetzung zur behandlung von störungen des blutzuckerstoffwechsels und verfahren zu ihrer herstellung
Aimutis Lactose cariogenicity with an emphasis on childhood dental caries
Al-Jobair et al. Evaluating the cariogenic potential of flavored milk: an experimental study using rat model
JP2004137278A (ja) イソマルトゥロース含有腸内栄養物の製造のための方法
Sato et al. Incorporation of a high level of vitamin B12 into a vegetable, kaiware daikon (Japanese radish sprout), by the absorption from its seeds
JP3979543B2 (ja) 抗アレルギー剤及びその製造法
Kalpe et al. How fad diets may jeopardize your oral well-being: The hidden consequences
JP3871262B2 (ja) 液状栄養組成物
Swetha et al. From plate to palate: Bridging nutrition and pediatric dental health
PT1194154E (pt) Utilizacao de bacterias propionicas para aproducao de acido propionico e/ou propinatos no colon
CN101277617A (zh) 治疗肌肉萎缩的含甜菜碱的营养品
JP2000262246A (ja) ヘリコバクターピロリの除菌剤
JP2025062550A (ja) 血圧降下用組成物
JP7281927B2 (ja) 心拍数低減剤
CN1097097A (zh) 活性钙口香糖
JP2003339400A (ja) ビタミン強化及び薬用効果を有する砂糖
TH64649B (th) องค์ประกอบทางโภชนาการสำหรับควบคุมระดับน้ำตาลในเลือด

Legal Events

Date Code Title Description
8363 Opposition against the patent
8365 Fully valid after opposition proceedings